Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (52)

2024

  1. Janus kinase inhibitors and tumour necrosis factor inhibitors show a favourable safety profile and similar persistence in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: real-world data from the BIOBADASER registry

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 9, pp. 1189-1199

2023

  1. A meta-analysis and a functional study support the influence of mtDNA variant m.16519C on the risk of rapid progression of knee osteoarthritis

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 974-984

  2. Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study

    RMD open, Vol. 9, Núm. 1

2022

  1. Multi-laboratory experiment PME11 for the standardization of phosphoproteome analysis

    Journal of Proteomics, Vol. 251

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Serum Proteomic Profiling in Rheumatoid Arthritis by Antibody Suspension Bead Arrays

    Methods in Molecular Biology (Humana Press Inc.), pp. 143-151

2020

  1. Association of serum anti-centromere protein F antibodies with clinical response to infliximab in patients with rheumatoid arthritis: A prospective study

    Seminars in Arthritis and Rheumatism, Vol. 50, Núm. 5, pp. 1101-1108

  2. Hydrogen sulfide biosynthesis is impaired in the osteoarthritic joint

    International Journal of Biometeorology, Vol. 64, Núm. 6, pp. 997-1010

2019

  1. Analysis of endogenous peptides released from osteoarthritic cartilage unravels novel pathogenic markers

    Molecular and Cellular Proteomics, Vol. 18, Núm. 10, pp. 2018-2028

  2. Anti-inflammatory effects of novel standardized platelet rich plasma releasates on knee osteoarthritic chondrocytes and cartilage in vitro

    Current Pharmaceutical Biotechnology, Vol. 20, Núm. 11, pp. 920-933

2018

  1. What did we learn from 'omics' studies in osteoarthritis

    Current Opinion in Rheumatology, Vol. 30, Núm. 1, pp. 114-120

2017

  1. A multicentric study to evaluate the use of relative retention times in targeted proteomics

    Journal of Proteomics, Vol. 152, pp. 138-149

  2. A replication study and meta-analysis of mitochondrial DNA variants in the radiographic progression of knee osteoarthritis

    Rheumatology (United Kingdom), Vol. 56, Núm. 2, pp. 263-270

  3. Defining the proteomic landscape of rheumatoid arthritis: progress and prospective clinical applications

    Expert Review of Proteomics, Vol. 14, Núm. 5, pp. 431-444

  4. Discovery of circulating proteins associated to knee radiographic osteoarthritis

    Scientific Reports, Vol. 7, Núm. 1

  5. MALDI mass spectrometry imaging in rheumatic diseases

    Biochimica et Biophysica Acta - Proteins and Proteomics, Vol. 1865, Núm. 7, pp. 784-794

  6. Mass spectrometry imaging: A novel technology in rheumatology

    Nature Reviews Rheumatology, Vol. 13, Núm. 1, pp. 52-63

  7. Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

    Journal of Proteomics, Vol. 152, pp. 216-225

  8. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

2016

  1. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5